FDA Inspection
Jazz Pharmaceuticals, IncJazz Pharmaceuticals, Inc – FDA Inspection, Mar 10, 2017
Record Details
This FDA Inspection record concerns Jazz Pharmaceuticals, Inc, with an inspection on March 10, 2017, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · adae928b-bffd-481e-a176-67a8c380c349
Inspection Facts
- Inspection number
- 1004087
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Jazz Pharmaceuticals, Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 10, 2019 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| July 20, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 27, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 4, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 30, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Jazz Pharmaceuticals, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.